Cargando…

Potential Role of Caffeine in the Treatment of Parkinson’s Disease

Parkinson’s disease [PD] is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting 1% of the population over the age of 55. The underlying neuropathology seen in PD is characterised by progressive loss of dopaminergic neurons in the substantia nigra pars compacta with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roshan, Mohsin H.K., Tambo, Amos, Pace, Nikolai P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962431/ https://www.ncbi.nlm.nih.gov/pubmed/27563362 http://dx.doi.org/10.2174/1874205X01610010042

Ejemplares similares

Testosterone and Cardiovascular Disease
por: Tambo, Amos, et al.
Publicado: (2016)

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
por: Roshan, Mohsin H. K., et al.
Publicado: (2016)

The role of testosterone in colorectal carcinoma: pathomechanisms and open questions
por: Roshan, Mohsin H. K., et al.
Publicado: (2016)

The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity
por: Tambo, Amos, et al.
Publicado: (2016)

Metformin as an adjuvant in breast cancer treatment
por: Roshan, Mohsin HK, et al.
Publicado: (2019)

Salivary caffeine in Parkinson’s disease
por: Leodori, Giorgio, et al.
Publicado: (2021)

Cautionary optimism: caffeine and Parkinson’s disease risk
por: Sokol, Leonard L., et al.
Publicado: (2016)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
por: Ren, Xiangpeng, et al.
Publicado: (2020)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson’s Disease
por: Kumar, Prakash M., et al.
Publicado: (2015)

The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
por: Hong, Chien Tai, et al.
Publicado: (2020)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study
por: Larsson, Susanna C., et al.
Publicado: (2022)

Drug treatment of Parkinson's disease
por: Korczyn, Amos D.
Publicado: (2004)

In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA(2A)R antagonists for the treatment of Parkinson's disease
por: Boulaamane, Yassir, et al.
Publicado: (2022)

Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjects
por: Ong, Yi-Lin, et al.
Publicado: (2023)

Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
por: Schepici, Giovanni, et al.
Publicado: (2020)

Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population
por: Yamada-Fowler, Naomi, et al.
Publicado: (2014)

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Caffein in Diseases of the Lung
Publicado: (1889)

Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
por: Ikram, Muhammad, et al.
Publicado: (2020)

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
por: Yan, Run, et al.
Publicado: (2018)

Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
por: Londzin, Piotr, et al.
Publicado: (2021)

The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment
por: Nowaczewska, Magdalena, et al.
Publicado: (2020)

Caffeine as a Potential Quorum Sensing Inhibitor
por: Norizan, Siti Nur Maisarah, et al.
Publicado: (2013)

The Potential Role of Voltage-Dependent Anion Channel in the Treatment of Parkinson's Disease
por: He, Yajie, et al.
Publicado: (2022)

Potential role of acupuncture in the treatment of Parkinson's disease: A narrative review
por: Park, Jaeyoung, et al.
Publicado: (2023)

Role of Caffeine in the Management of Androgenetic Alopecia
por: Bansal, Manish, et al.
Publicado: (2012)

Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview
por: SC, Yenisetti, et al.
Publicado: (2016)

Editorial comments: treatment of motor fluctuations in Parkinson’s disease
por: Korczyn, Amos D.
Publicado: (2011)

The Role of Clomipramine in Potentiating the Teratogenic Effects of Caffeine in Pregnant Rats: A Histopathological Study
por: Nikoui, Vahid, et al.
Publicado: (2013)

Potential Role of Mic60/Mitofilin in Parkinson’s Disease
por: Van Laar, Victor S., et al.
Publicado: (2019)

Potential Activity of the Purine Compounds Caffeine and Aminophylline on Bacteria
por: AL-Janabi, Ali Abdul Hussein S
Publicado: (2011)

Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson’s disease according to task demands
por: Sharma, Kanch, et al.
Publicado: (2022)

The Potential Role of Astrocytes in Parkinson’s Disease (PD)
por: Hindeya Gebreyesus, Hiluf, et al.
Publicado: (2020)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Caffeine: What Is Its Role in Pain Medicine?
por: Boppana, Sri Harsha, et al.
Publicado: (2022)

Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study
por: Crotty, Grace F., et al.
Publicado: (2020)

Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kiutek3aefrmmvjh69nfqdjlbo